Please login to the form below

Not currently logged in
Email:
Password:

INC Research acquires Middle Eastern CRO

Purchase of MEK Consulting expands its geographic footprint

INC Research has expanded its geographic footprint across the Middle East, north Africa and southern Europe by acquiring Lebanon-based contract research organisation (CRO) MEK Consulting.

MEK, which also has offices in Greece and Turkey, is a clinical monitoring-focused CRO with more than 40 employees.

INC chief executive Jamie Macdonald said: "The Middle East and north Africa region offers significant opportunities for new drug development due to its large patient populations, highly qualified medical personnel and increasingly sophisticated regulatory environments.

"The acquisition of MEK Consulting provides INC Research's customers with access to this expanding region for biopharmaceutical development and further demonstrates our commitment to connect them to everything they need to conduct their trials."

MEK will now operate under the INC Research name but it will continue to be led by founders Myriam El-Khazen and Selim Dagher, who become general manager and executive director, commercial operations, respectively.

Myriam El-Khazen said: "We believe this acquisition will bring the MENA region and southern Europe to a new era in clinical research. This will be advantageous for our customers, the patients in the region and our company.”

7th March 2014

From: Research

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...